K O S PHARMACEUTICALS INC
KOSP
KOSP was delisted on the 14th of December, 2006.
0 hedge funds and large institutions have $0 invested in K O S PHARMACEUTICALS INC in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $629K → $0 (-$629K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DWM
Dechtman Wealth Management
Centennial,
Colorado
|
-$454K |
| 2 |
TVWM
Tower View Wealth Management
Shorewood,
Wisconsin
|
-$175K |
KOSP Hedge Fund Activity: Q3 2023 in Review
0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q3 2023, worth a combined $0 — down 100% from $629K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KOSP and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Dechtman Wealth Management, exiting entirely with an estimated $454K sold.
- 0 institutional investors held K O S PHARMACEUTICALS INC (KOSP) as of Q3 2023, down from 2 in Q2 2023.
- Funds reported $0 of K O S PHARMACEUTICALS INC stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new K O S PHARMACEUTICALS INC positions in Q3 2023 and 2 closed out, a net change of -2 holders.
- The largest K O S PHARMACEUTICALS INC seller in Q3 2023 was Dechtman Wealth Management, an estimated $454K sold.
Based on aggregated 13F filings for Q3 2023.